These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26813372)

  • 1. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].
    Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension.
    Zhang Y; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Li X; An C; Ma X; Xiong C; Luo Q; Liu Z
    Clin Exp Rheumatol; 2021; 39(5):1063-1070. PubMed ID: 33200733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
    Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
    Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
    Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
    BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation of cardiopulmonary exercise test in patients with idiopathic pulmonary arterial hypertension].
    Luo Q; Liu ZH; Ma XP; Zhao ZH; Gu Q; Xiong CM; Ni XH; He JG; Zhao Q
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1683-6. PubMed ID: 24124671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between submaximal exercise measurements and peak oxygen uptake in patients with pulmonary arterial hypertension].
    Shi X; Liu J; Guo J; Yang W; Liu H; Huang D; Wu C; Gong S; Zhao Q; He J; Wang L
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(32):2490-4. PubMed ID: 25410918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
    Tang Y; Yao L; Liu Z; Ma X; Luo Q; Zhao Z; Huang Z; Tu L; Gao L; Jin Q; Ni X; Xiong C
    Pulm Pharmacol Ther; 2017 Apr; 43():26-31. PubMed ID: 28159512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between left ventricular diastolic function and plasma natriuretic peptide level in children with pulmonary artery hypertension secondary to congenital heart disease].
    Cui H; Hu YX; Feng ZC
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan; 12(1):13-6. PubMed ID: 20113626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [End tidal PCO(2) for evaluation of severity of disease in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    Shi X; Yang GL; Chen Y; Guo J; Yang WL; Yuan P; Gong SG; Jiang R; Zhao QH; Wang L; He J; Chen TX; Liu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):34-39. PubMed ID: 28100360
    [No Abstract]   [Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between N-Terminal Pro-Brain Natriuretic Peptide Levels and Cardiopulmonary Exercise Testing in Patients With Pre-Capillary Pulmonary Hypertension: A Pilot Study.
    Aueyingsak S; Khrisanapant W; Kukongviriyapun U; Pasurivong O; Ratanawatkul P; Wanitpongpan C; Pussadhamma B
    Clin Med Insights Circ Respir Pulm Med; 2020; 14():1179548420954049. PubMed ID: 33117035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.
    Rhee RL; Gabler NB; Sangani S; Praestgaard A; Merkel PA; Kawut SM
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1111-7. PubMed ID: 26291092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Kuang HY; Li Q; Du HA; Chen M; Yin YH
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):181-191. PubMed ID: 32918210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension.
    Morris NR; Seale H; Harris J; Hall K; Lin AC; Kermeen F
    Respirology; 2017 Jan; 22(1):165-171. PubMed ID: 27530086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential serum lipid distribution in IPAH and CHD-PAH patients.
    Chen J; Rathinasabapathy A; Luo J; Yang X; Luo P; Chen Y; Li Z; Li J
    Respir Med; 2022 Jan; 191():106711. PubMed ID: 34890866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
    J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
    Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.